β₃-AR Antibodies

Santa Cruz Biotechnology features a diverse variety of β₃-AR monoclonal antibodies for studying the β₃-adrenergic receptor, a key player in the regulation of energy metabolism and thermogenesis. β₃-AR monoclonal antibodies support multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The β₃-adrenergic receptor is primarily expressed in adipose tissue and plays a crucial role in lipolysis and the regulation of body weight. Its activation has been linked to increased energy expenditure and improved metabolic health, making it a significant target for obesity and diabetes research. Understanding the function of the β₃-adrenergic receptor is essential for developing therapeutic strategies aimed at metabolic disorders. β₃-AR monoclonal antibodies enable detailed investigation of receptor expression patterns across different tissues. Research utilizing β₃-AR monoclonal antibodies from Santa Cruz Biotechnology continues to advance our understanding of metabolic regulation and support the development of new therapeutic approaches.